Markus Pietsch

Prof. Dr. Markus Pietsch

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2015 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
AAAlexander Aslanidis
Alexander Aslanidis
MKMarcus Karlstetter
Marcus Karlstetter
RSRebecca Scholz
Rebecca Scholz
SFSascha Fauser
Sascha Fauser
HNHarald Neumann
Harald Neumann
TLThomas Langmann
Thomas Langmann
Microglia reactivity is a hallmark of neurodegenerative diseases. We have previously identified activated microglia/macrophage whey acidic protein (AMWAP) as a counter-regulator of pro-inflammatory response. Here, we studied its mechanisms of action with a focus on toll-like receptor (TLR) and nuclear factor κB (NFκB) signaling. Recombinant AMWAP was produced in Escherichia coli and HEK293 EBNA cells and purified by affinity chromatography. AMWAP uptake was identified by fluorescent labeling, and pro-inflammatory microglia markers were measured by qRT-PCR after stimulation with TLR ligands. NFκB pathway proteins were assessed by immunocytochemistry, Western blot, and immunoprecipitation. A 20S proteasome activity assay was used to investigate the anti-peptidase activity of AMWAP. Microglial neurotoxicity was estimated by nitrite measurement and quantification of caspase 3/7 levels in 661W photoreceptors cultured in the presence of microglia-conditioned medium. Microglial proliferation was investigated using flow cytometry, and their phagocytosis was monitored by the uptake of 661W photoreceptor debris. AMWAP was secreted from lipopolysaccharide (LPS)-activated microglia and recombinant AMWAP reduced gene transcription of IL6, iNOS, CCL2, CASP11, and TNFα in BV-2 microglia treated with LPS as TLR4 ligand. This effect was replicated with murine embryonic stem cell-derived microglia (ESdM) and primary brain microglia. AMWAP also diminished pro-inflammatory markers in microglia activated with the TLR2 ligand zymosan but had no effects on IL6, iNOS, and CCL2 transcription in cells treated with CpG oligodeoxynucleotides as TLR9 ligand. Microglial uptake of AMWAP effectively inhibited TLR4-dependent NFκB activation by preventing IRAK-1 and IκBα proteolysis. No inhibition of IκBα phosphorylation or ubiquitination and no influence on overall 20S proteasome activity were observed. Functionally, both microglial nitric oxide (NO) secretion and 661W photoreceptor apoptosis were significantly reduced after AMWAP treatment. AMWAP promoted the filopodia formation of microglia and increased the phagocytic uptake of apoptotic 661W photoreceptor cells. AMWAP is secreted from reactive microglia and acts in a paracrine fashion to counter-balance TLR2/TLR4-induced reactivity through NFκB inhibition. AMWAP also induces a neuroprotective microglial phenotype with reduced neurotoxicity and increased phagocytosis. We therefore hypothesize that anti-inflammatory whey acidic proteins could have a therapeutic potential in neurodegenerative diseases of the brain and the retina.

18 April 2013 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
APAshok D. Pehere
Ashok D. Pehere
MPMarkus Pietsch
Markus Pietsch
Michael GütschowMichael Gütschow
Michael Gütschow
PNPaul M. Neilsen
Paul M. Neilsen
DPDaniel Sejer Pedersen
Daniel Sejer Pedersen
Andrew AbellAndrew Abell
Andrew Abell

1 March 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MPMarkus Pietsch
Markus Pietsch
KVKaido Viht
Kaido Viht
ASAlexander Schnitzler
Alexander Schnitzler
RERamesh Ekambaram
Ramesh Ekambaram
MSMichaela Steinkrüger
Michaela Steinkrüger
Karsten NiefindKarsten Niefind
Karsten Niefind

20 February 2019 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
DLDirk Lindenblatt
Dirk Lindenblatt
MHMareike Horn
Mareike Horn
CGClaudia Götz
Claudia Götz
Karsten NiefindKarsten Niefind
Karsten Niefind
Ines NeundorfInes Neundorf
Ines Neundorf
MPMarkus Pietsch
Markus Pietsch

1 January 2015 in Analytical Biochemistry
Verified
Journal Article
Closed access
JHJennifer Hochscherf
Jennifer Hochscherf
DLDirk Lindenblatt
Dirk Lindenblatt
MSMichaela Steinkrüger
Michaela Steinkrüger
EYEungyoung Yoo
Eungyoung Yoo
ÖUÖzlem Ulucan
Özlem Ulucan
MPMarkus Pietsch
Markus Pietsch

7 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EEEhab El-Awaad
Ehab El-Awaad
GPGalyna Pryymachuk
Galyna Pryymachuk
CFCora Fried
Cora Fried
JMJan Matthes
Jan Matthes
JIJoerg Isensee
Joerg Isensee
MPMarkus Pietsch
Markus Pietsch
The α2δ‐1 subunit of voltage-gated calcium channels binds to gabapentin and pregabalin, mediating the analgesic action of these drugs against neuropathic pain. Extracellular matrix proteins from the thrombospondin (TSP) family have been identified as ligands of α2δ‐1 in the CNS. This interaction was found to be crucial for excitatory synaptogenesis and neuronal sensitisation which in turn can be inhibited by gabapentin, suggesting a potential role in the pathogenesis of neuropathic pain. Here, we provide information on the biochemical properties of the direct TSP/α2δ-1 interaction using an ELISA-style ligand binding assay. Our data reveal that full-length pentameric TSP-4, but neither TSP-5/COMP of the pentamer-forming subgroup B nor TSP-2 of the trimer-forming subgroup A directly interact with a soluble variant of α2δ-1 (α2δ-1S). Interestingly, this interaction is not inhibited by gabapentin on a molecular level and is not detectable on the surface of HEK293-EBNA cells over-expressing α2δ‐1 protein. These results provide biochemical evidence that supports a specific role of TSP-4 among the TSPs in mediating the binding to neuronal α2δ‐1 and suggest that gabapentin does not directly target TSP/α2δ-1 interaction to alleviate neuropathic pain.